Jacc. Heart Failure
Overview
JACC. Heart Failure is a peer-reviewed medical journal that focuses on the latest advancements in heart failure research and clinical practice. It provides a platform for cardiologists, researchers, and healthcare professionals to publish high-quality articles, original research, and expert reviews in the field of heart failure. The journal aims to improve patient outcomes by disseminating cutting-edge knowledge and promoting evidence-based approaches to the prevention, diagnosis, and management of heart failure.
Details
Details
Abbr.
JACC Heart Fail
Publisher
Elsevier
Start
2013
End
Continuing
Frequency
Bimonthly
p-ISSN
2213-1779
e-ISSN
2213-1787
Country
United States
Language
English
Metrics
Metrics
h-index / Ranks: 2815
106
SJR / Ranks: 206
5724
CiteScore / Ranks: 271
22.40
JIF / Ranks: 290
13.0
Recent Articles
1.
Gallone G, Savoca F, Miccoli D, Bohm M, De Ferrari G, Gottlieb S, et al.
JACC Heart Fail
. 2025 Mar;
PMID: 40088236
Background: Patients with heart failure with reduced ejection fraction (HFrEF) have a heightened stroke risk. However, stroke as an endpoint in heart failure trials remains under-reported. Objectives: The authors sought...
2.
Sankaranarayanan R, Hartshorne-Evans N, Hornby K, Barton C, Hyland R, Campbell G, et al.
JACC Heart Fail
. 2025 Mar;
PMID: 40088235
No abstract available.
3.
Docherty K, McDowell K, Welsh P, Petrie M, Anand I, Berg D, et al.
JACC Heart Fail
. 2025 Mar;
PMID: 40088234
Background: Inflammation may play an important pathophysiological role in the development and progression of heart failure (HF). Interleukin (IL)-6 is a circulating cytokine and is the main regulator of the...
4.
Kondo T, Jhund P, Anand I, Claggett B, Desai A, Docherty K, et al.
JACC Heart Fail
. 2025 Mar;
PMID: 40088233
Background: Recent trials of new heart failure (HF) treatments suggest the effect of therapy may vary by N-terminal pro-B type natriuretic peptide (NT-proBNP) level. Objectives: The authors examined the efficacy...
5.
Fiuzat M, Ferlin K, Gottschalk L, Farb A, Cavagna I, Lindenfeld J, et al.
JACC Heart Fail
. 2025 Mar;
PMID: 40088232
No abstract available.
6.
Amano M, Kitaoka H, Yoshikawa Y, Sakata Y, Dohi K, Tokita Y, et al.
JACC Heart Fail
. 2025 Mar;
PMID: 40088231
Background: To prevent sudden cardiac death (SCD) in patients with hypertrophic cardiomyopathy (HCM), the HCM Risk-SCD calculator and guideline recommendations are used to aid decision making for implantable cardioverter-defibrillator placement....
7.
Karlstrom P, Pivodic A, Fu M
JACC Heart Fail
. 2025 Mar;
PMID: 40088230
Background: Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have shown improved symptomatic relieving and functional capacity in patients with heart failure (HF) with preserved ejection fraction and obesity. Objectives: The purpose...
8.
9.
Sankaranarayanan R, Hartshorne-Evans N, Mclean L, Jones J, Salla M, Chakrabarti B, et al.
JACC Heart Fail
. 2025 Mar;
PMID: 40047766
No abstract available.
10.